JDTic dihydrochloride is a potent kappa-opioid receptor (KOR) antagonist commonly used in research on neurological disorders; it dose-dependently blocks the antinociceptive response of nicotine in the tail-flick test in mice; reverses anxiety-like behavior in a rat model of hangover anxiety; decreases alcohol self-administration and suppresses cue-induced reinstatement of alcohol seeking; specifically blocks the effects of a KOR agonist at the 2-hour pretreatment time point; and significantly inhibits U50,488-induced diuresis in rats.